9
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Mechanism of Toxicity and Rationale for Use of the Combination of Pentazocine and Pyribenzamine in Morphine-Dependent Subjects

Pages 175-188 | Published online: 25 Sep 2008

References

  • Parachini A. Tie 39 county deaths to drug mix. Chicago Sun Times March 20, 1978; 31(40)3
  • Anonymous. Pentazocine Abuse Rises‐Schedule IV Status Proposed. FDA Drug Bull. 1978; 8: 34
  • Showalter C. V., Moore L. Abuse of pentazocine and tripelen‐namine. J. Am. Med. Assoc 1978; 239: 1610
  • Lahmeyer H. W., Steingold R. G. Pentazocine and tripelen‐namine‐A drug abuse epidemic, Submitted for Publication
  • Waller D. P., Katz N. L., Morris R. W. Potentiation of lethality in mice by combinations of pentazocine and tripelen‐namine. Clin. Toxicol. 1980; 16: 17
  • Thompson E. B., Bhargava H. N. Naloxone (NLX) reversal of cardiorespiratory (CR) function during toxic interaction between pentazocine (P) and tripelennamine (T). Fed. Proc. 1979; 38: 681
  • Bhargava H. N. Effects of pentazocine and pyribenzamine on withdrawal responses in morphine dependent mice. Pharmacologist 1979; 2: 157
  • Bhargava H. N. The effects of naltrexone on the development of physical dependence on morphine. Eur. J. Pharmacol. 1978; 50: 193
  • Litchfield J. T., Wilcoxon F. A simplified method for evaluating dose‐effect experiments. J. Pharmacol. Exp. Ther. 1949; 96: 99
  • Bhargava H. N. Rapid induction and quantitation of morphine dependence induced by pellet implantation. Psychopharmacology 1977; 52: 55
  • Bhargava H. N. Effects of methionine enkephalin and morphine on spontaneous locomotor activity: Antagonism by naloxone. Pharmacol. Biochem. Behav. 1978; 9: 167
  • Bhargava H. N. Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome. Pharmacol. Bio‐chem. Behav. 1978; 8: 7
  • Martin W. R., Eades C. G., Thompson J. A., Huppler R. D., Gilbert P. E. The effects of morphine‐ and nalorphine‐like drugs in the nondependent and morphine‐dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976; 197: 517

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.